NON-ALCOHOLIC STEATOHEPATITIS
Clinical trials for NON-ALCOHOLIC STEATOHEPATITIS explained in plain language.
Never miss a new study
Get alerted when new NON-ALCOHOLIC STEATOHEPATITIS trials appear
Sign up with your email to follow new studies for NON-ALCOHOLIC STEATOHEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for fatty liver: Stomach-Shrinking procedure may beat diet alone
Disease control Recruiting nowThis study tests whether a minimally invasive procedure called endoscopic sleeve gastroplasty (ESG), which reduces stomach size by about 70%, combined with lifestyle changes, can reverse fatty liver disease (MASH) better than lifestyle changes alone. About 132 adults with obesity…
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS
Phase: NA • Sponsor: Pichamol Jirapinyo, MD, MPH • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New combo test could catch liver disease earlier
Diagnosis Recruiting nowThis study aims to improve how doctors detect early liver scarring (fibrosis) by combining standard blood tests with new markers, genetic analysis, and gut bacteria testing. Researchers will study 1200 adults referred to a liver clinic. The goal is to identify advanced liver dise…
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS
Sponsor: Manchester University NHS Foundation Trust • Aim: Diagnosis
Last updated Apr 29, 2026 15:15 UTC
-
New study seeks to uncover why some liver patients develop cancer
Knowledge-focused Recruiting nowThis study aims to find out why some people with fatty liver disease or alcohol-related liver disease develop liver cancer. Researchers will study genetic markers and immune factors in 710 adults, both with and without cirrhosis. The goal is to identify early warning signs, espec…
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated May 01, 2026 15:57 UTC
-
800 patients help scientists create liver disease models
Knowledge-focused Recruiting nowThis study collects tissue and blood samples from 800 people with chronic liver disease or liver cancer. Researchers will use these samples to create lab models, like cell clusters and mouse tumors, to test new treatments. The goal is to better understand these diseases and devel…
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:48 UTC
-
Healthy volunteers needed to test first safety of new fatty liver pill
Knowledge-focused Recruiting nowThis early-stage study tests a new drug called HEC169584 in 96 healthy adults aged 18-45. The main goal is to see if the drug is safe and how the body processes it. This is a first step toward possibly treating non-alcoholic steatohepatitis (NASH), a serious fatty liver disease.
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS
Phase: PHASE1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:04 UTC